Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

Leave a Comment / By Market Social / January 21, 2026

Big pharma is grappling with new drug pricing deals and roughly $300 billion in potential lost revenue from patent expirations of blockbuster drugs.

Post navigation

ServiceNow inks deal with OpenAI to boost its AI software stack

Bessent says Trump’s pick for the next Fed chair could happen next week

Your email address will not be published. Required fields are marked *

Comment *

Name*

Email*

Website

Save my name, email, and website in this browser for the next time I comment.

Markets

Trading

About Us

Name * Only alphabets are allowed.

Password

Again Password

Referral (Optional)

Support Language

Whatsapp Number *

OTP